🧬 This Week in Vaccine Research: Cancer Vaccines, Exosome-Based Trials, Polio Innovation & More
This week’s Vaccine Research roundup highlights cutting-edge updates in the world of vaccines—from promising cancer vaccine trials to new developments in exosome-based vaccines and oral polio formulations. Stay on top of the latest breakthroughs and insights shaping the future of vaccine innovation.
🔬 Key highlights:
💉 Novel Vaccine Shows Early Immune Responses in Pancreatic and Colorectal Cancers
🦠 Capricor Therapeutics launches Phase 1 trial for exosome-based vaccine targeting SARS-CoV-2 and emerging threats
⚖️ FluMist nasal spray to be available for at-home use starting in the 2025-2026 flu season
❌ AAP recommends COVID-19 vaccination for children as young as six months
🧊 Oxford University and Upperton Pharma collaborate on oral vaccine formulation to improve global immunization access
🧪 Pfizer’s COVID-19 vaccine approved in Canada for new Omicron variant LP.8.1
🌍 International study tests a vaccine against 21 strains of pneumococcus
🦠 Oral polio vaccines show promise in Phase 1 trials with strong immune responses
📢 Stay Ahead in Vaccine Research!
✅ Like, share, and subscribe for weekly updates on the latest vaccine breakthroughs
#VaccineResearch #CancerVaccines #PolioVaccines #COVID19Vaccines #VaccineInnovation #PublicHealth #ClinicalTrials #ExosomeVaccines #VaccineBreakthroughs #GlobalHealth #LucidQuest #InfectiousDiseases #Pharmaceuticals #Healthcare #VaccineDevelopment #SubscribeNow